RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway

Dan Wang, Xing Niu, Jingqi Tian, Ruibin Liu, Yuxuan Song, Dingye Zhang, Junze Dai, Shenglong Li, Xudong Zhu
Oncogene · Springer Nature · 2026-11-05 · DOI: 10.1038/s41388-026-04007-0

Abstract

Oncogene, Published online: 05 November 2026; doi:10.1038/s41388-026-04007-0 RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway

Read at publisher →

Similar articles